The real story in Chile is about access to medicines, says the first woman heading its pharma association

12 June 2019

Marta Diez (pictured above) is the first woman president of Cámara de la Innovación Farmacéutica (CIF), a group representing 23 pharma multinationals with a presence in Chile.

She is the country manager of Pfizer (NYSE: PFE) Chile, and her experience in pharma has seen her work across therapy areas including infectious diseases and pain management, and allowed her to get to know overseas markets in Europe, the Middle East and Africa.

This CV made Mrs Diez a strong choice for the two-year role of representing the pharmaceutical industry in Chile, but the fact that she is the first woman to be chosen inevitably grabbed some headlines.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK